167 related articles for article (PubMed ID: 10804293)
21. Phototoxic effect of na-pheophorbide a toward osteosarcoma cells in vitro using a laser diode.
Nagai Y; Aizawa S; Iriuchishima T; Goto B; Nagaoka M; Tokuhashi Y; Saito A
Photomed Laser Surg; 2014 Sep; 32(9):481-9. PubMed ID: 25105597
[TBL] [Abstract][Full Text] [Related]
22. Acridine Orange as a Novel Photosensitizer for Photodynamic Therapy in Glioblastoma.
Osman H; Elsahy D; Saadatzadeh MR; Pollok KE; Yocom S; Hattab EM; Georges J; Cohen-Gadol AA
World Neurosurg; 2018 Jun; 114():e1310-e1315. PubMed ID: 29631084
[TBL] [Abstract][Full Text] [Related]
23. A new therapeutic modality involving acridine orange excitation by photon energy used during reduction surgery for rhabdomyosarcomas.
Matsubara T; Kusuzaki K; Matsumine A; Murata H; Satonaka H; Shintani K; Nakamura T; Hosoi H; Iehara T; Sugimoto T; Uchida A
Oncol Rep; 2009 Jan; 21(1):89-94. PubMed ID: 19082447
[TBL] [Abstract][Full Text] [Related]
24. The safety and efficiency of photodynamic therapy for the treatment of osteosarcoma: A systematic review of in vitro experiment and animal model reports.
Tan G; Xu J; Yu Q; Yang Z; Zhang H
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103093. PubMed ID: 36031143
[TBL] [Abstract][Full Text] [Related]
25. Acridine orange exhibits photodamage in human bladder cancer cells under blue light exposure.
Lin YC; Lin JF; Tsai TF; Chen HE; Chou KY; Yang SC; Tang YM; Hwang TI
Sci Rep; 2017 Oct; 7(1):14103. PubMed ID: 29074848
[TBL] [Abstract][Full Text] [Related]
26. mTHPC-mediated photodynamic therapy is effective in the metastatic human 143B osteosarcoma cells.
Reidy K; Campanile C; Muff R; Born W; Fuchs B
Photochem Photobiol; 2012; 88(3):721-7. PubMed ID: 22268498
[TBL] [Abstract][Full Text] [Related]
27. Recurrence analysis of intraoperative acridine orange-photodynamic therapy for dogs with intranasal tumors.
Maruo T; Fukuyama Y; Nishiyama Y; Nemoto Y; Kanai E; Kawarai S; Kayanuma H; Orito K
Can Vet J; 2021 Oct; 62(10):1117-1122. PubMed ID: 34602642
[TBL] [Abstract][Full Text] [Related]
28. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
29. Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925.
Yang X; Yang P; Shen J; Osaka E; Choy E; Cote G; Harmon D; Zhang Z; Mankin H; Hornicek FJ; Duan Z
Br J Cancer; 2014 Jun; 110(12):2896-904. PubMed ID: 24853187
[TBL] [Abstract][Full Text] [Related]
30. The enhancing effect of a laser photochemotherapy with cisplatin or zolendronic acid in primary human osteoblasts and osteosarcoma cells in vitro.
Heymann PG; Ziebart T; Kämmerer PW; Mandic R; Saydali A; Braun A; Neff A; Draenert GF
J Oral Pathol Med; 2016 Nov; 45(10):803-809. PubMed ID: 27122094
[TBL] [Abstract][Full Text] [Related]
31. A new limb salvage surgery in cases of high-grade soft tissue sarcoma using photodynamic surgery, followed by photo- and radiodynamic therapy with acridine orange.
Nakamura T; Kusuzaki K; Matsubara T; Matsumine A; Murata H; Uchida A
J Surg Oncol; 2008 May; 97(6):523-8. PubMed ID: 18348188
[TBL] [Abstract][Full Text] [Related]
32. miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo.
Duan Z; Gao Y; Shen J; Choy E; Cote G; Harmon D; Bernstein K; Lozano-Calderon S; Mankin H; Hornicek FJ
Mol Oncol; 2017 Feb; 11(2):151-166. PubMed ID: 28145098
[TBL] [Abstract][Full Text] [Related]
33. Characterization of acidic vesicles in multidrug-resistant and sensitive cancer cells by acridine orange staining and confocal microspectrofluorometry.
Millot C; Millot JM; Morjani H; Desplaces A; Manfait M
J Histochem Cytochem; 1997 Sep; 45(9):1255-64. PubMed ID: 9283613
[TBL] [Abstract][Full Text] [Related]
34. Radiodynamic therapy with acridine orange local administration as a new treatment option for primary and secondary bone tumours.
Matsuyama Y; Nakamura T; Yoshida K; Hagi T; Iino T; Asanuma K; Sudo A
Bone Joint Res; 2022 Oct; 11(10):715-722. PubMed ID: 36214462
[TBL] [Abstract][Full Text] [Related]
35. Benzochloroporphyrin derivative induced cytotoxicity and inhibition of tumor recurrence during photodynamic therapy for osteosarcoma.
Gong HY; Sun MX; Hu S; Tao YY; Gao B; Li GD; Cai ZD; Yao JZ
Asian Pac J Cancer Prev; 2013; 14(5):3351-5. PubMed ID: 23803128
[TBL] [Abstract][Full Text] [Related]
36. A new therapeutic proposal for inoperable osteosarcoma: Photodynamic therapy.
de Miguel GC; Abrantes AM; Laranjo M; Grizotto AYK; Camporeze B; Pereira JA; Brites G; Serra A; Pineiro M; Rocha-Gonsalves A; Botelho MF; Priolli DG
Photodiagnosis Photodyn Ther; 2018 Mar; 21():79-85. PubMed ID: 29175213
[TBL] [Abstract][Full Text] [Related]
37. Aminolevulinic Acid-Mediated Photodynamic Therapy Causes Cell Death in MG-63 Human Osteosarcoma Cells.
White B; Rossi V; Baugher PJ
Photomed Laser Surg; 2016 Sep; 34(9):400-5. PubMed ID: 27500317
[TBL] [Abstract][Full Text] [Related]
38. Aloe-emodin-mediated photodynamic therapy induces autophagy and apoptosis in human osteosarcoma cell line MG‑63 through the ROS/JNK signaling pathway.
Tu P; Huang Q; Ou Y; Du X; Li K; Tao Y; Yin H
Oncol Rep; 2016 Jun; 35(6):3209-15. PubMed ID: 27035222
[TBL] [Abstract][Full Text] [Related]
39. Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
Meier D; Botter SM; Campanile C; Robl B; Gräfe S; Pellegrini G; Born W; Fuchs B
Int J Cancer; 2017 Apr; 140(7):1680-1692. PubMed ID: 27943293
[TBL] [Abstract][Full Text] [Related]
40. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.
Cenni V; Maraldi NM; Ruggeri A; Secchiero P; Del Coco R; De Pol A; Cocco L; Marmiroli S
Int J Oncol; 2004 Dec; 25(6):1599-608. PubMed ID: 15547696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
